Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Influence of rimonabant on lower esophageal function in healthy volunteers
2008-006081-29Phase 4Completed
- Sponsor
- UZ Leuven
- Start
- Oct 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of rimonabant in gastroesophageal reflux disease (GERD), sponsored by UZ Leuven. Primary endpoints: Esophageal contractility and Lower esophageal sphincter tone. Started Oct 2008; status: completed.
02
Drugs
rimonabant
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on 2008-006081-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-006081-29.